Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,400
Closed -$42.4K 6462
2025
Q4
$42.4K Buy
+31,400
New +$31.6K ﹤0.01% 4634
2020
Q2
Sell
-6
Closed -$2K 7700
2020
Q1
$2K Hold
6
﹤0.01% 7449
2019
Q4
$5K Buy
6
+5
+500% +$6K ﹤0.01% 7408
2019
Q3
$1K Sell
1
-6
-86% -$9.62K ﹤0.01% 7637
2019
Q2
$14K Buy
+7
New +$14.2K ﹤0.01% 7212

Other funds holding YCBD

Citigroup's YCBD Position: Q1 2026 in Review

Citigroup sold out of cbdMD (YCBD) in Q1 2026, closing a stake of 31,400 shares — an estimated $42.4K sold.

Citigroup first reported a position in YCBD in Q2 2019 and held it in 5 quarters. The position peaked at $42.4K in Q4 2025. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • Citigroup reported no remaining cbdMD position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 31,400 cbdMD shares in Q1 2026, an estimated $42.4K.
  • Citigroup first reported a position in cbdMD in Q2 2019 and held it in 5 quarters.
  • Citigroup's cbdMD position peaked at $42.4K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.